Partner Content Partner Content GSK explores Oral Lipid Based Formulations & Taste Maski... GSK explores Oral Lipid Based Formulations
Partner Content Partner Content Agenda released for SMi Group’s Controlled Release Delivery ... Agenda released for Controlled Release Delivery 2018
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
